About Us

Based in South Florida, Organicell™ is a publicly traded biotechnology company committed to the research, development and manufacture of new biologic medicine, with a focus on current and potential regenerative therapeutics. Organicell™ is the leading, fully integrated Biologic Medicine Company. Our mission is to transform regenerative medicine by continuing to combine nano-technology with other synergistic therapies and become the healthcare incubator for biologic medicine.

Executive Leadership

Albert Mitrani
Dr. Maria Ines Mitrani, M.D., PhD
George Shapiro, M.D., FACC
Ian T. Bothwell

Science & Regulatory Advisory Board

Michael A. Bellio, Ph.D.
Ivan Santos
Julian Milberg
Zanub Abdullah

Medical Advisory Board

Allen J. Meglin, M.D.
Bryan Kelly, M.D.
Carolyn DeLucia, M.D.
Paul Thompson, M.D.
Marianne LaBarbera, M.D.
Paul Francis Campion, M.D.
Sonita Sadio, M.D.
Henry C. Sobo, M.D.
Henry C. Sobo, M.D.
Rolf Wallin, M.D.
Dr. Robert Madda, M.D.
Raymond Ishman, M.D.
William K. Kapp III, M.D., M.S., FAAOS
Stephanie M. Singer, D.O.
Dr. Julian Gershon, D.O.
Rebecca Murray, F.N.P.
Juan Chavez, M.D.
Fernando Pinto, M.D.
Michale J. Barber, M.D.
Alvaro J. Ocampo, M.D. MPH
David C. Socol, M.D.
John R. Baird, M.D.
Ken Sharlin, M.D., M.P.H., IFMCP
Randolph Whipps, M.D., F. A.C.C.
Riley J. Williams III, M.D.
Barry Kuttner, M.D., PhD
Mounir Wassef, D.O., FAOCD, FAAD
Robert Neal Rouzier, M.D.
Bennett L. Willard, D.O.
Dan Sperling, M.D., D.A.B.R.
Glenn Charles, D.O.
Eugene Rajaratnam, M.D., F.A.C.S.
Matthew Lief, M.D., F.A.C.S.
Josh Sandell, D.C., D.A.C.B.S.P., A.T.C., C.S.C.S., I.C.S.S.D.
Billy Ray Ledbetter, M.D.
Mohammed Siddiqui, M.D.
Matthew Burnett, D.C., C.C.S.M.S, C.F.S.S.

Financial & Regulatory
Advisory Board

Larry Ziff

Strategic Advisors

Raymond Zoeller